We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alkermes’ Opioid Dependency Treatment Vivitrol Gains FDA Nod
Alkermes’ Opioid Dependency Treatment Vivitrol Gains FDA Nod
October 15, 2010
Approval of Alkermes’ Vivitrol as the only drug for prevention of relapse to opioid dependence will differentiate the treatment from other drugs, according to the company.